SPDR S&P Biotech ETF Rating $99.19 -2.40 (-2.36%) (As of 09/23/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy2.78Holdings in XBI have an aggregate rating of Moderate Buy based on 702 analyst ratings issued in the past year covering 50 companies (75.7% of the portfolio).XBI Aggregate Price Target$127.2328.27% UpsideHigh Prediction$168.24Average Prediction$127.23Low Prediction$86.68Holdings in XBI have an aggregate price target of $127.23 and a range of $86.68 to $168.24 covering 50 companies (75.7% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.61%EXASExact Sciences$69.64-0.6%4.2878 of 5 stars4.29 / 5 stars3.00$78.14 12.2%153.24%GILDGilead Sciences$83.99+0.1%4.6008 of 5 stars4.60 / 5 stars2.45$82.06 -2.3%203.08%UTHRUnited Therapeutics$355.59+0.7%4.664 of 5 stars4.66 / 5 stars2.64$357.17 0.4%14Analyst ForecastPositive News3.06%ABBVAbbVie$193.82+0.2%4.8505 of 5 stars4.85 / 5 stars2.93$191.64 -1.1%152.90%ALNYAlnylam Pharmaceuticals$271.83-0.7%4.1524 of 5 stars4.15 / 5 stars2.71$279.14 2.7%242.85%AMGNAmgen$335.61-0.5%4.6836 of 5 stars4.68 / 5 stars2.55$327.28 -2.5%222.84%REGNRegeneron Pharmaceuticals$1,091.98-4.6%4.2325 of 5 stars4.23 / 5 stars2.85$1,111.30 1.8%20Analyst ForecastHigh Trading Volume2.72%NTRANatera$123.54-3.3%1.7279 of 5 stars1.73 / 5 stars3.00$120.07 -2.8%15Insider Selling2.63%BMRNBioMarin Pharmaceutical$69.13-2.2%4.9867 of 5 stars4.99 / 5 stars2.68$98.84 43.0%222.56%SRPTSarepta Therapeutics$124.79-1.9%4.8772 of 5 stars4.88 / 5 stars2.95$187.39 50.2%19Analyst ForecastAnalyst Revision2.56%VKTXViking Therapeutics$65.01-7.7%4.193 of 5 stars4.19 / 5 stars3.09$108.60 67.1%11Insider SellingOptions Volume2.53%VRTXVertex Pharmaceuticals$460.00-1.1%4.3946 of 5 stars4.39 / 5 stars2.50$486.36 5.7%26Positive News2.49%INCYIncyte$64.12-2.5%4.8624 of 5 stars4.86 / 5 stars2.32$73.24 14.2%192.24%BIIBBiogen$195.81-1.8%4.8646 of 5 stars4.86 / 5 stars2.68$275.30 40.6%25Analyst Forecast2.00%NBIXNeurocrine Biosciences$117.75-0.5%4.9895 of 5 stars4.99 / 5 stars2.83$162.20 37.7%241.98%CYTKCytokinetics$52.09-3.1%4.4274 of 5 stars4.43 / 5 stars2.73$80.67 54.9%15Analyst Forecast1.54%PCVXVaxcyte$112.11-2.7%3.4657 of 5 stars3.47 / 5 stars3.00$147.50 31.6%7Positive NewsGap Up1.47%MRNAModerna$64.14-2.4%4.5072 of 5 stars4.51 / 5 stars2.11$100.44 56.6%19Gap Up1.41%ROIVRoivant Sciences$11.90-0.6%3.6535 of 5 stars3.65 / 5 stars2.90$17.39 46.1%10High Trading Volume1.32%APLSApellis Pharmaceuticals$32.72+0.6%4.3517 of 5 stars4.35 / 5 stars2.80$70.53 115.6%15Analyst Forecast1.28%EXELExelixis$26.36-0.2%4.4213 of 5 stars4.42 / 5 stars2.67$27.67 5.0%15Analyst Forecast1.20%MDGLMadrigal Pharmaceuticals$225.72-3.3%4.2269 of 5 stars4.23 / 5 stars2.69$343.83 52.3%13Analyst Upgrade1.16%CRSPCRISPR Therapeutics$46.74-3.0%2.6119 of 5 stars2.61 / 5 stars2.37$75.63 61.8%191.14%BPMCBlueprint Medicines$90.06-1.8%3.2082 of 5 stars3.21 / 5 stars2.74$120.00 33.2%19Positive News1.14%BBIOBridgeBio Pharma$25.40-5.0%4.7214 of 5 stars4.72 / 5 stars2.92$47.92 88.6%121.12%INSMInsmed$71.82-3.2%4.2254 of 5 stars4.23 / 5 stars3.00$81.40 13.3%161.11%TGTXTG Therapeutics$23.25-5.7%4.6205 of 5 stars4.62 / 5 stars2.83$31.83 36.9%61.09%ALKSAlkermes$28.10-1.6%4.6005 of 5 stars4.60 / 5 stars2.55$36.70 30.6%111.08%RVMDRevolution Medicines$42.63-6.1%4.0704 of 5 stars4.07 / 5 stars3.09$53.45 25.4%111.08%KRYSKrystal Biotech$180.18-2.2%4.6526 of 5 stars4.65 / 5 stars3.00$196.75 9.2%9Positive News1.08%HALOHalozyme Therapeutics$58.53-1.2%4.732 of 5 stars4.73 / 5 stars2.67$60.00 2.5%91.00%IONSIonis Pharmaceuticals$41.83-2.2%4.2857 of 5 stars4.29 / 5 stars2.71$60.68 45.1%21Positive News0.98%BHVNBiohaven$45.93+13.7%3.6753 of 5 stars3.68 / 5 stars3.08$54.70 19.1%13Analyst ForecastNews CoverageGap UpHigh Trading Volume0.98%RAREUltragenyx Pharmaceutical$57.56-2.0%4.7425 of 5 stars4.74 / 5 stars2.93$87.43 51.9%140.89%ACLXArcellx$85.98-0.7%0.5135 of 5 stars0.51 / 5 stars3.07$78.00 -9.3%15Gap Up0.86%IOVAIovance Biotherapeutics$9.66-4.8%4.1806 of 5 stars4.18 / 5 stars2.88$23.00 138.1%80.85%SWTXSpringWorks Therapeutics$32.88-4.4%1.8304 of 5 stars1.83 / 5 stars3.00$68.50 108.3%6Positive News0.79%CRNXCrinetics Pharmaceuticals$50.42-5.1%4.4327 of 5 stars4.43 / 5 stars2.91$68.55 35.9%110.79%NUVLNuvalent$102.05-5.5%1.3633 of 5 stars1.36 / 5 stars2.92$111.00 8.8%12High Trading Volume0.72%FOLDAmicus Therapeutics$11.22-0.6%4.022 of 5 stars4.02 / 5 stars2.89$17.00 51.5%9Analyst Forecast0.70%CLDXCelldex Therapeutics$40.17-2.6%1.3666 of 5 stars1.37 / 5 stars2.86$63.83 58.9%7Gap Up0.68%ADMAADMA Biologics$20.03+0.3%2.3867 of 5 stars2.39 / 5 stars3.25$15.50 -22.6%4Analyst ForecastHigh Trading Volume0.67%ACADACADIA Pharmaceuticals$16.29-1.5%4.482 of 5 stars4.48 / 5 stars2.69$25.56 56.9%160.66%DYNDyne Therapeutics$34.63-5.4%4.05 of 5 stars4.05 / 5 stars3.10$51.40 48.4%10Analyst Forecast0.64%VERAVera Therapeutics$44.56+4.2%1.9635 of 5 stars1.96 / 5 stars3.11$51.75 16.1%9Analyst Forecast0.62%RNAAvidity Biosciences$43.50-2.2%3.1567 of 5 stars3.16 / 5 stars3.00$61.00 40.2%7Insider Selling0.61%IDYAIDEAYA Biosciences$33.73-3.6%4.4239 of 5 stars4.42 / 5 stars3.08$56.20 66.6%13News CoverageGap UpHigh Trading Volume0.59%TWSTTwist Bioscience$45.29-2.5%2.3224 of 5 stars2.32 / 5 stars2.78$48.22 6.5%90.59%KYMRKymera Therapeutics$49.98+0.4%1.0055 of 5 stars1.01 / 5 stars2.77$48.67 -2.6%13Positive News0.59%GERNGeron$4.28-9.1%3.744 of 5 stars3.74 / 5 stars3.00$7.06 65.0%9Gap Up This page (NYSEARCA:XBI) was last updated on 9/23/2024 by MarketBeat.com Staff From Our PartnersElection Shocker: Trump Won't See This ComingIf you suspect Democrats will play dirty games in this election… You are RIGHT! Executive Order 14019 ha...Banyan Hill Publishing | SponsoredInvesting Legend Warns: “Disturbing Event Is Coming to America”America Repeats Act That's Destroyed Stock Markets For 200 Years The Fed has now repeated a mistake that ce...Stansberry Research | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding SPDR S&P Biotech ETF You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBI Stock Alerts